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Summary at a glance 
It is unclear whether the attenuated bronchodilatory response to deep inspiration (DI) in 
asthma is related to an inflammatory environment. Using whole bronchial segments in 
vitro, we show that culture with pro-inflammatory cytokines, TNF and IL-1β, increases 
airway narrowing but does not affect the bronchodilatory response to DI. 
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Abstract 
Background and objective: Whilst chronic inflammation of the airway wall and the 
failure of deep inspiration (DI) to produce bronchodilation are both common to asthma, 
whether pro-inflammatory cytokines modulate the airway smooth muscle (ASM) 
response to strain during DI is unknown. The primary aim of the study was to determine 
how an inflammatory environment (simulated by the use of pro-inflammatory 
cytokines) alters the bronchodilatory response to DI. 
 
Methods: We used whole porcine bronchial segments in vitro that were cultured in 
medium containing tumour necrosis factor (TNF) and interleukin-1β (IL-1β) for 2 days. 
A custom-built servo-controlled syringe pump and pressure transducer was used to 
measure airway narrowing and to simulate tidal breathing with intermittent DI 
manoeuvres. 
 
Results: Culture with TNF and IL-1β increased airway narrowing to acetylcholine but 
did not affect the bronchodilatory response to DI. 
 
Conclusions: The failure of DI to produce bronchodilation in patients with asthma may 
not necessarily involve a direct effect of pro-inflammatory cytokines on airway tissue. 
A relationship between inflammation and airway hyper-responsiveness is supported, 
however, regulated by separate disease processes than those which attenuate or abolish 
the bronchodilatory response to DI in patients with asthma. 
 
Keywords: asthma, bronchoconstriction, inflammation, cytokines and strain 
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Airway hyper-responsiveness (AHR) is a primary characteristic of asthma1 and is 
considered a major contributor to airflow limitation2, 3. The cause(s) of AHR remain 
unclear but may involve abnormalities in airway smooth muscle (ASM) 
structure/function following chronic inflammation of the airway wall present in patients 
with asthma4. Increased levels of pro-inflammatory cytokines, such as tumour necrosis 
factor (TNF) and interleukin-1β (IL-1β), which are released from numerous cell types, 
including mast cells5, have been detected in the sputum of patients with symptomatic 
asthma5-11. Changes in ASM force production in the presence of TNF7-10 and/or IL-1β7, 
11 could, theoretically, contribute to AHR. 
 
More recently, the dynamic mechanical environment of the lung has been identified as 
an important regulator of airway responsiveness and may be susceptible to 
inflammatory disease processes, contributing to AHR12. In normal healthy individuals 
in vivo, deep inspiration (DI) produces a transient (i.e. for ~1 to 2min) reversal of 
bronchoconstriction (i.e. bronchodilation) to a number of different inhaled ASM 
contractile agonists13-16. However, the bronchodilatory response to DI is attenuated or 
abolished in patients in asthma14-16. The underlying mechanism by which DI produces 
bronchodilation is thought to involve a strain-induced decrease in ASM force17-21, due 
to perturbed cross-bridge binding19, 20 and/or de-polymerisation of the contractile 
apparatus22. Whilst chronic inflammation of the airway wall and the failure of DI to 
produce bronchodilation are both common to asthma, whether pro-inflammatory 
cytokines modulate the ASM response to strain and therefore, the bronchodilatory 
response to DI, is unknown. 
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The primary aim of the study was to determine how an inflammatory environment 
(simulated by the use of pro-inflammatory cytokines) alters the bronchodilatory 
response to DI, in a manner similar to how airway narrowing is expected to increase and 
contribute to AHR. We hypothesised that culturing airway segments in medium 





Animal handling and bronchial segment preparation 
All animal experiments conformed to institutional ethics and animal care unit 
regulations (Animal Ethics Committee, University of Western Australia, Crawley, WA, 
Australia). Bronchial segments, ~25mm long, were dissected from male White 
Landrace pigs (n=18, ~35kg)21, 23, 24. The mode generation was 18 at the distal and 12 at 
the proximal end (where the generation of the trachea=0), with an internal diameter of 
~2mm at the distal and ~3mm at the proximal ends. 
 
Bronchial segment culture 
Prior to culturing, cannulated bronchial segments were washed in bovine serum albumin 
containing 1% penicillin/streptomycin, 0.5% gentamycin and 1% Amphotericin B under 
sterile conditions. Bronchial segments were cultured in Dulbecco’s modified Eagle 
medium (DMEM) containing 1% penicillin/streptomycin, 0.5% gentamycin, 1% L-
glutamine and 2% foetal bovine serum (FBS) at 37°C with 5% CO2, 5% humidity. The 
culture medium was replaced every 24hr to remove the effect of metabolites produced 
by the tissue. In the TNF+IL-1β treatment group, the culture medium always contained 
human TNF (100ng/mL) and human IL-1β (20ng/mL). The use of TNF and IL-1β was 
based on a systematic literature search, which identified these pro-inflammatory 
cytokines as playing a potentially important role in asthma pathophysiology. 
 
Organ bath and syringe pump 
The bronchial segment was mounted horizontally in an organ bath, connected to a liquid 
filled servo-controlled syringe pump and pressure transducer, used to measure lumen 
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volume and to apply fixed-transmural pressure (Ptm) oscillations (i.e. tidal breathing and 
DI manoeuvres)21, 25, 26 (Figure 1). 
 
Protocol 1: Contractile response of bronchial segments before and after culture 
Airways were studied in the organ bath fresh (i.e. within ~1hr of being dissected and 
prior to culture) and again on day 2 of culture without pro-inflammatory cytokines 
(n=6). Small fixed-Ptm oscillations, simulating tidal breathing (∆5cmH2O at 0.25Hz), 
were also briefly applied in the relaxed state to calculate the specific compliance of the 
airway wall. Following oscillation, airway narrowing dose-response curves (DRC) were 
constructed to ACh (10-7 to 3x10-3M) under static conditions (5cmH2O Ptm). 
 
Protocol 2: Effect of TNF and IL-1β on bronchodilation to DI airway narrowing 
Airways were studied on day 2 of culture in the control (left or right lower lobe) and 
TNF+IL-1β treatment group (alternate lower lobe, n=6 per group). DRCs were 
constructed to ACh (10-7 to 3x10-3M) under both static (5cmH2O Ptm) and oscillatory 
conditions in a randomised order, separated by 45min. The oscillatory protocol 
comprised tidal breathing (∆5cmH2O at 0.25Hz) and intermittent DI manoeuvres 
(∆25cmH2O, a 2s inflation, a 2s hold at the peak of inflation and a 2s deflation) applied 
once contraction at each dose of ACh had plateaued21. To assess whether any changes in 
airway narrowing observed with TNF and IL-1β were as a result of increased ASM 
force, in a separate group of airways, DRCs were constructed to ACh under isovolumic 




After experimentation, bronchial segments were fixed in 4% formaldehyde solution and 
processed into paraffin blocks. Transverse sections (5μm) were stained with 
haematoxylin and eosin. The internal lumen perimeter (Pi) and area (Ai), the area 
enclosed by the outer ASM perimeter (Amo) and area of the ASM layer27 were measured 
using ImageJ (version 1.45j, National Institutes of Health, MD, U.S.A.). The area of the 
ASM layer was expressed as √area of the ASM layer/Pi. 
 
Analysis and statistics 
The volume of the relaxed airway lumen was measured by the volume that could be 
withdrawn until closure at 5cmH2O Ptm28. Airway narrowing to ACh was expressed as 
%lumen volume. Active lumen pressure to ACh was measured from the change in Ptm. 
Dynamic measurements were made at the troughs of the pressure cycle. Maximum 
response (Emax) and sensitivity (PD2=–log10, dose producing 50% Emax) to ACh was 
calculated from variable slope sigmoidal curves fitted to individual airways. Specific 
compliance was calculated from volume strain (Δvolume/lumen volume)/ΔPtm24, 28, 29. 
 
The ASM strain during breathing manoeuvres (ΔPtm) was calculated from the trough to 
peak change in the outer ASM perimeter (Pmo) during DI as a proportion of the Pmo 
immediately prior to DI. The Pmo of the bronchial segment in the organ bath was 
calculated as previously described21, 25, 26 and assumes inner wall area is constant at all 
Ptm, that Pmo is circular and that the lumen is cylindrical. The bronchodilatory response 
to DI was defined as %reversal of airway narrowing to ACh measured immediately 
after DI24, 28, 29. Bronchodilation to DI was not calculated at doses (≤3x10-6M), which 
produced minimal airway narrowing. 
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Differences between groups were analysed using paired t-tests and 2-way ANOVA. 
Data analysis and statistical tests were performed using Statistica (version 8.0; StatSoft, 
Tulsa, OK, U.S.A.) and GraphPad Prism (version 5.0d; GraphPad Software, La Jolla, 




Protocol 1: Contractile response of bronchial segments before and after culture 
After 2 days in culture without pro-inflammatory cytokines, there was a non-significant 
decrease in Emax (p=0.11) but no difference in PD2 (Figure 2). There was no difference 
in specific compliance after culture (fresh before culture 0.010±0.0024cmH2O-1; after 
0.017±0.0048cmH2O-1). Histological examination revealed denuding of the airway 
epithelium after culture. 
 
Protocol 2:  Effect of TNF and IL-1β on bronchodilation to DI airway narrowing 
Following 2 days of culture in medium containing TNF+IL-1β, there was no difference 
in lumen volume, Pi, area of the ASM layer or specific compliance of the airway wall in 
the relaxed state, compared to the control group (Table 1). Under static conditions, 
airway narrowing (Figure 3A) and active lumen pressure (Figure 3B) Emax was greater 
in the TNF+IL-1β treatment group, compared with the control group. There was no 
difference in PD2 between groups. 
 
Airways stiffened strongly in response to ACh (Figure 4A). Further, when expressed as 
the change in specific compliance from the relaxed state, airway wall stiffening to ACh 
was greater in the TNF+IL-1β treatment group, compared with the control group 
(Figure 4B). 
 
The primary aim of the study was to determine how an inflammatory environment 
(simulated by the use of pro-inflammatory cytokines) alters the bronchodilatory 
response to DI. Scatter plots of bronchodilation measured immediately after DI against 
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the ASM strain produced by DI had linear lines-of-best-fit fitted to individual airways 
(Table 2). The average linear lines-of-best-fit are shown in Figure 5A. Bronchodilation 
was positively correlated with ASM strain for all airways in both groups (i.e. greater 
bronchodilation with increasing ASM strain during DI). However, there was no 
difference in the average intercept or slope of the lines fitted between bronchodilation 
and ASM strain between groups. Bronchodilation to DI fell substantially with 
increasing dose of ACh (Figure 5B). There was also no difference in the 
bronchodilatory response to DI between groups at comparable doses of ACh. This result 
was the same whether bronchodilation was measured immediately after DI or at the 




In addition to AHR, a reduced bronchodilatory response to DI is now believed to play 
an important role in asthma pathophysiology. A reduced bronchodilatory response to DI 
has recently been shown to correlate with the perception of dyspnoea in subjects with 
asthma29, although the mechanism for the dysfunction is unknown. The present study 
determined how pro-inflammatory cytokines, TNF and IL-1β, alters the bronchodilatory 
response to DI in bronchial segments. Results show that whilst culture with TNF and 
IL-1β increases airway narrowing, it does not affect the bronchodilatory response to DI. 
 
Before discussing the significance of our findings, there are aspects of the methodology 
that require discussion. Airway function was modelled using whole bronchial segments, 
which retain the normal morphology of the airway wall, tissue-to-tissue interactions and 
physiological loading conditions. Culturing relatively large segments of tissue for an 
extended period is challenging due to a potential restriction in the supply of nutrients or 
the removal of metabolites. There was epithelial loss after two days in culture, which 
likely occurred as a result of restricted luminal perfusion of nutrients. The impaired 
epithelial barrier did not increase airway narrowing, since in the present study 
contractile agonists were delivered to the serosal surface30. There was, instead, a non-
significant decrease in maximum response to ACh after 2 days of culture, consistent 
with studies using ASM strips/rings9, 11. Although the presence of FBS is necessary to 
provide appropriate mitogen/survival signals, it may have contributed to the decrease in 
airway responsiveness31. Importantly, FBS was present in both the control and TNF+IL-
1β treatment groups. Finally, TNF and IL-1β were used in combination to increase our 
chances of observing an effect on the bronchodilatory response to DI and/or airway 
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narrowing. The drawback of this approach is that we are therefore unable to identify the 
separate effects of these cytokine and it is also possible that they may operate in 
opposition. 
 
Previous studies examining airway responsiveness in vitro following pro-inflammatory 
cytokines have done so under static conditions (i.e. in the absence of oscillatory ASM 
strain associated with breathing manoeuvres)7-11. Given that the dynamic mechanical 
environment is now considered an important regulator of airway caliber12, we 
questioned whether pro-inflammatory cytokines would impact the normal response to 
DI. Our results showed that 2 days of culture with TNF and IL-1β did not affect ASM 
response to strain during DI, which suggests that inflammation may not directly alter 
bronchodilation to DI. It remains unclear how other pro-inflammatory cytokines, such 
as interleukins 2, 4, 5 and 6 (IL-2, IL-4, IL-5 and IL-6) or granulocyte macrophage 
colony stimulating factor (GM-CSF)5, 6 impact bronchodilation to DI. 
 
One limitation of our study was that due to concerns regarding tissue viability, it was 
not possible to extend the cytokine exposure beyond 48hrs and while this was sufficient 
to modify ASM force and narrowing, this does not necessarily mean the response to DI 
will be similarly affected. There is however evidence that the response to mechanical 
strain elicited by DI can be modified by inflammation within a much shorter period of 
exposure than that used in the present study. The response to DI in human subjects is 
disrupted 4hrs after ozone exposure32, which the authors concluded was most likely due 
to an induced inflammatory event, previously shown to occur 3hrs after ozone 
exposure33. In vitro, force induced re-lengthening of isolated ASM, analogous to 
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bronchodilation produced by DI, was enhanced by corticosteroid treatment after only 
2hrs34. While there is likely to be a direct effect of corticosteroids on ASM 
contraction34, length oscillation of ASM increases inflammatory gene expression 
(including IL-1β)35, supporting possible interaction between mechanical perturbation of 
the ASM, the inflammatory cascade and response to corticosteroids. 
 
Evidence for an association between airway inflammation and response to DI in human 
subjects is nonetheless mixed. One study reported an inverse association between 
bronchodilation to DI and mast cells and CD4+ lymphocytes in the airways of subjects 
with mild asthma, but not COPD36, while another study showed no such relationship 
between any inflammatory cell in mild asthma37. There is evidence that the impaired 
response to DI in asthma can be therapeutically targeted with anti-inflammatories. 
Bronchodilation response to DI was improved in subjects with asthma following a two-
week course of oral corticosteroids38. Putting our own findings in context, if the 
bronchodilatory response to DI is disrupted by an inflammatory cascade, our data 
suggests that the underlying mechanism may not be related to an alteration in the airway 
wall response to mechanical strain. The response to DI in vivo is a balance between 
hysteresis of the airway wall and hysteresis of the surrounding lung parenchyma39, the 
latter of which reduces bronchodilation. It is therefore possible that increased 
parenchymal inflammation, rather than airway inflammation, contributes to a reduced 




Our laboratory21, 41 and others42 have previously shown that ASM strain is the critical 
determinant of bronchodilation to DI. By use of fixed-Ptm DI, the amplitude of DI and 
the stiffness of the airway wall determine the magnitude of ASM strain. Under high 
levels of ASM activation where the airway wall stiffens, the magnitude of ASM strain 
becomes negligible and the bronchodilatory response to DI is attenuated. In both 
groups, bronchodilation to fixed Ptm DI fell substantially with increasing dose of ACh 
but there was no difference in the lines fitted between bronchodilation and ASM strain. 
The critical level of ASM strain required to produce bronchodilation was ~3%, which 
was not affected by culture with TNF and IL-1β. In the diseased state, a reduction in the 
magnitude of ASM strain produced by DI below 3% (e.g., as a result of excessive 
airway wall stiffening) could abolish the bronchodilatory response to DI, without 
necessarily modulating the relationship between ASM strain and bronchodilation. The 
reduced response to DI in patients with asthma may, therefore, be due to airway wall 
stiffening43 possibly as a consequence of airway remodelling, and not a direct result of 
exposure to pro-inflammatory cytokines. 
 
A new finding is the apparent change in the ASM response to strain during DI 
following 2 days of culture, compared with fresh bronchial segments in our previous 
study21 (Figure 6). Increasing ASM strain produced less bronchodilation following 
culture (i.e. the slope of the lines fitted between bronchodilation and ASM strain was 
steeper in fresh bronchial segments, compared to the control group in the present study). 
Since we observed denudation of the airway epithelium with culture, this raises the 
possibility that the release of epithelial-derived mediators contributes to the 
bronchodilatory response to DI. Brown and Mitzner44 showed in dogs in vivo, 
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bronchodilation to DI is abolished by inhibiting nitric oxide (NO) synthesis. However, 
in pilot studies, blocking NO synthesis (L-NOARG), or manual denudation of the 
epithelium (data not shown) did not attenuate the bronchodilatory response to DI. An 
alternative possibility is that there is a phenotypic change to the ASM in culture 
whereby the response to mechanical strain is modified, as has been proposed to occur in 
asthma45 
 
We confirm the findings of numerous studies in vitro7-11, where culture with TNF 
and/or IL-1β increased maximum isometric ASM force under static conditions (i.e. 
without breathing stresses and strains), which in the present study, was reflected by an 
increase in maximum active lumen pressure to ACh. The ASM force hyper-contractility 
following culture with TNF and IL-1β (~40% increase in maximum active lumen 
pressure to ACh) we found in whole bronchial segments was somewhat greater than that 
reported in isolated ASM strips, where there was an ~8 to ~30% increase in maximum 
isometric force to ACh7, 8, 10. Differences in pro-inflammatory cytokine-induced hyper-
contractility between studies are likely explained by relative concentrations: TNF 
(100ng/mL) and IL-1β (20ng/mL) in the present study, compared to 10 to 100ng/mL 
and/or 10 to 25ng/mL, respectively, in previous studies. There are some contrary 
findings in the literature, such as the study by Wills-Karp and colleagues46, who report 
no effect of TNF and/or IL-1β on contractile response. 
 
We found no difference in the area of the ASM layer, suggesting that the increase in 
ASM force is due to an increase in ASM contractility. The ASM hyper-contractility 
could occur as a result of a TNF-induced increase in intra-cellular Ca2+ release from the 
 19 
sarcoplasmic reticulum47-49, Ca2+-sensitization through the G-protein coupled receptor 
RhoA/Rho kinase pathway50 and/or an IL-1β-induced up-regulation of TNF mRNA 
expression11. 
 
The underlying assumption of studies demonstrating enhanced isometric force is that 
this will also increase ASM shortening in the presence of normal mural mechanical 
afterloads. We now extend previous findings to show that the increase in ASM force 
due to TNF and IL-1β is sufficient to increase maximum airway narrowing by ~23% 
lumen volume, which was made possible using our bronchial segment model. To our 
knowledge, no previous studies in vitro, have shown an increase in airway narrowing, 
as opposed to isometric ASM force, following culture with pro-inflammatory cytokines. 
In contrast to the increase in maximum response to ACh produced by TNF and IL-1β, 
we found no difference in sensitivity, which is also consistent with studies using ASM 
strips and/or rings8-10. 
 
With greater cytokine-mediated ASM force production, airway stiffness is also expected 
to increase if there are more bound cross-bridges.  An increase in airway wall stiffness 
will intuitively decrease the magnitude of ASM strain during DI at the same dose of 
ACh. While there was no difference in airway wall stiffness between groups at 
comparable doses of ACh, the change in specific compliance (reduction) from the 
relaxed state was greater in the TNF+IL-1β treatment group. Despite enhanced airway 
stiffening with TNF+IL-1β exposure, the bronchodilatory response to DI was unaltered 
at any dose of ACh. 
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In conclusion, culture with TNF and IL-1β increases airway narrowing but does not 
affect bronchodilation to DI. The failure of DI to produce bronchodilation in patients 
with asthma may not necessarily involve a direct effect of pro-inflammatory cytokines 
on airway tissue. A relationship between inflammation and airway hyper-
responsiveness is supported, however, regulated by separate disease processes than 
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Table 1. Lumen volume, internal perimeter (Pi), area of the ASM layer and specific 
compliance of the airway wall in the control and TNF+IL-1β treatment groups. 
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Volume (μL) 




















There was no difference in lumen volume, Pi, area/thickness of the ASM layer or 




Table 2. Slope, intercept and Pearson’s correlation coefficients for scatter plots of 
bronchodilation against ASM strain. 
































































Bronchodilation is the %reversal in airway narrowing following DI and ASM strain is 
the change in Pmo produced by DI in the control (airway 1 to 6, left or right lower lobe) 






Figure 1. Example traces of transmural pressure (Ptm, above) and lumen volume 
(below) to cumulative doses of acetylcholine (ACh, 10-7 to 3x10-3M, arrows, text labels 
shown only for whole log doses). Fixed-Ptm oscillations were applied to control airways 
and airways treated with TNF (100ng/mL)/IL-1β (20ng/mL). Traces from the control 
and TNF+IL-1β treatment groups have been temporally shifted to better distinguish the 
curves. At the time scale shown, tidal oscillations are not visible but appear as a thick 
line, the thickness of which indicates the magnitude of the Ptm and volume oscillations. 
Individual DI are visible prior to the subsequent dose of ACh. In response to ACh, 
lumen volume decreased in a dose-dependent manner. Stiffening of the airway wall 




Figure 2.The effect of culture on maximum response (Emax, %lumen volume, A) and 
sensitivity (PD2, B) to ACh under static conditions. There was a non-significant 
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reduction in Emax following 2 days of culture (66.8±14.5% lumen volume), compared 
with the fresh airway before culture (100.0±0.0% lumen volume i.e. airway closure in 
all airways, p=0.11). There was no difference in PD2 following 2 days of culture 






Figure 3. Cumulative DRC to ACh (10-7 to 3x10-3M) for airway narrowing (%Lumen 
Volume, A) and active lumen pressure (ΔcmH2O, B) in the control and TNF+IL-1β 
treatment groups. Culture with TNF and IL-1β increased both airway narrowing 
(control group; 77.7±7.8% lumen volume, TNF+IL-1β treatment group; 95.3±2.1% 
lumen volume, p<0.05) and active lumen pressure (control group; 51.4±11.1cmH2O, 
TNF+IL-1β treatment group; 72.2±6.0cmH2O, p<0.05). There was no difference in PD2 
between groups for airway narrowing (control group; 5.54±0.22, TNF+IL-1β treatment 
group; 4.94±0.12) or active lumen pressure (control group; 4.95±0.26, TNF+IL-1β 




Figure 4. Specific compliance of the airway wall (cmH2O-1, A) in the relaxed state and 
in airways narrowed to ACh (10-7 to 3x10-3M), as well as the change in specific 
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compliance from the relaxed state (ΔcmH2O-1, B) in the control and TNF+IL-1β 
treatment groups. Airways stiffened strongly in response to ACh (control group; 
0.0129±0.0011cmH2O-1 in the relaxed state, to 0.0057±0.0011cmH2O-1, p<0.001, 
TNF+IL-1β treatment group; 0.0185±0.0034cmH2O-1 in the relaxed state, to 
0.0050±0.0010cmH2O-1, p<0.001). There was no difference in airway specific 
compliance between groups. The change in specific compliance from the relaxed state 






Figure 5. Scatter plots of bronchodilation (%Reversal) against ASM strain (A) 
produced by DI and bronchodilation to DI (%Reversal, B) in airways narrowed to ACh 
(10-5 to 3x10-3M) in the control and TNF+IL-1β treatment groups. Plots comprise 6 
measurements per airway in A. Linear lines-of-best fit were fitted to individual airways 
and average intercept and slope was used to construct an average linear line-of-best-fit 
for each group. Bronchodilation to DI was positively correlated with ASM strain. There 
was no difference in the average intercept (control group; 0.029±0.011, TNF+IL-1β 
treatment group; 0.032±0.007) and slope between groups (control group; 262.6±61.4, 
TNF+IL-1β treatment group; 284.8±83.5). Bronchodilation to DI fell substantially with 
increasing dose of ACh (control; 16.7±3.7% reversal at 10-5M ACh to 2.0±1.0% 
reversal, p<0.001, TNF+IL-1β treatment; 20.4±4.3% reversal at 10-5M ACh to 
3.5±2.1% reversal, p<0.001). There was no difference in bronchodilation to DI in both 




Figure 6. The effect of culture on strain-induced bronchodilation. Scatter plots of 
bronchodilation (%Reversal) against ASM strain produced by fixed–Ptm DI. Airways 
from the control and TNF+IL-1β treatment group in the present study are compared 
with fresh bronchial segments from our previous study21. Whilst there was no difference 
between the control and TNF+IL-1β treatment groups, both groups had a reduced 
bronchodilatory response to DI, compared with fresh bronchial segments. The average 
slope was greater in the fresh bronchial segments than the control (p<0.05) and 
TNF+IL-1β treatment (p<0.05) groups. n=6. 
